Postnatal Proteasome Inhibition Induces Neurodegeneration and Cognitive Deficiencies in Adult Mice: A New Model of Neurodevelopment Syndrome
Rocío Romero-Granados,Ángela Fontán-Lozano,Francisco Javier Aguilar-Montilla,Angel M. Carrión +3 more
Reads0
Chats0
TLDR
In this paper, the effects of deficient proteasome activity during early postnatal development are poorly understood, and the effect of such dysfunction on the behavior of adult mice is investigated.Abstract:
Defects in the ubiquitin-proteasome system have been related to aging and the development of neurodegenerative disease, although the effects of deficient proteasome activity during early postnatal development are poorly understood. Accordingly, we have assessed how proteasome dysfunction during early postnatal development, induced by administering proteasome inhibitors daily during the first 10 days of life, affects the behaviour of adult mice. We found that this regime of exposure to the proteasome inhibitors MG132 or lactacystin did not produce significant behavioural or morphological changes in the first 15 days of life. However, towards the end of the treatment with proteasome inhibitors, there was a loss of mitochondrial markers and activity, and an increase in DNA oxidation. On reaching adulthood, the memory of mice that were injected with proteasome inhibitors postnatally was impaired in hippocampal and amygdala-dependent tasks, and they suffered motor dysfunction and imbalance. These behavioural deficiencies were correlated with neuronal loss in the hippocampus, amygdala and brainstem, and with diminished adult neurogenesis. Accordingly, impairing proteasome activity at early postnatal ages appears to cause morphological and behavioural alterations in adult mice that resemble those associated with certain neurodegenerative diseases and/or syndromes of mental retardation.read more
Citations
More filters
Journal ArticleDOI
Protein damage, repair and proteolysis.
Niki Chondrogianni,Isabelle Petropoulos,Stefanie Grimm,Konstantina Georgila,Betul Catalgol,Bertrand Friguet,Tilman Grune,Efstathios S. Gonos +7 more
TL;DR: Genetic modulation has produced promising results in the area of protein repair enzymes but there are not yet any identified potent inhibitors, and, to the authors' knowledge, only one activating compound has been reported so far.
Journal ArticleDOI
Role of early life exposure and environment on neurodegeneration: implications on brain disorders.
TL;DR: This review summarizes both the animal and human studies describing various environmental stimuli to which an individual or an animal is exposed during in-utero and postnatal period and mechanisms that promote neurodegeneration.
Journal ArticleDOI
Proteasome activation delays aging in vitro and in vivo
Niki Chondrogianni,Marianthi Sakellari,Maria Lefaki,Nikoletta Papaevgeniou,Efstathios S. Gonos +4 more
TL;DR: The means of function of these proteasome activators and how they regulate aging in various species are reported on.
Book ChapterDOI
The amazing ubiquitin-proteasome system: structural components and implication in aging.
TL;DR: It is proposed that mild UPS activation in the young organism will, likely, promote antiaging effects and/or suppress age-related diseases.
Journal ArticleDOI
Stress and Psychiatric Disorders: The Role of Mitochondria.
TL;DR: The evidence for mitochondrial dysfunction as a consequence of stress exposure and as a contributing factor to psychiatric disease is reviewed and evaluated.
References
More filters
Journal ArticleDOI
The Ubiquitin System
Avram Hershko,Aaron Ciechanover +1 more
TL;DR: This review discusses recent information on functions and mechanisms of the ubiquitin system and focuses on what the authors know, and would like to know, about the mode of action of ubi...
Journal ArticleDOI
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
Michael T. Lin,M. Flint Beal +1 more
TL;DR: Treatments targeting basic mitochondrial processes, such as energy metabolism or free-radical generation, or specific interactions of disease-related proteins with mitochondria hold great promise in ageing-related neurodegenerative diseases.
Journal ArticleDOI
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
Luca Santarelli,Michael Saxe,Cornelius Gross,Alexandre Surget,Fortunato Battaglia,Stephanie C. Dulawa,Noelia V. Weisstaub,James T. Lee,Ronald S. Duman,Ottavio Arancio,Catherine Belzung,René Hen +11 more
TL;DR: It is shown that disrupting antidepressant-induced neurogenesis blocks behavioral responses to antidepressants, suggesting that the behavioral effects of chronic antidepressants may be mediated by the stimulation of neuroGenesis in the hippocampus.
Journal ArticleDOI
Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus
TL;DR: Investigation of the effect of antidepressants on hippocampal neurogenesis in the adult rat using the thymidine analog bromodeoxyuridine (BrdU) as a marker for dividing cells demonstrates that chronic antidepressant treatment significantly increases the number of BrdU-labeled cells in the dentate gyrus and hilus of the hippocampus.
Journal ArticleDOI
Protein aggregation and neurodegenerative disease.
TL;DR: There is increased understanding of the pathways involved in protein aggregation, and some recent clues have emerged as to the molecular mechanisms of cellular toxicity, leading to approaches toward rational therapeutics.